Investors
-
Non Regulatory June 26, 2026Vivesto completes recruitment in Paccal Vet dog pilot study – topline results expected Q3 2026
-
Non Regulatory June 16, 2026Vivesto reports positive results from i.v. Cantrixil PK/toxicology study
-
Regulatory June 5, 2026Vivesto appoints Björn Svanström as CFO
Vivesto published its interim report for Q1 2026 on May 7, 2026, at 08.00 am CEST.